Maravai LifeSciences Holdings, Inc. (MRVI) Capital expenditures 2019–2025
Maravai LifeSciences Holdings, Inc. (MRVI) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$13.1MFY2025 · since FY2019: $17.1M → $13.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $13.1M | -55.7% |
| FY2024 | $29.7M | -54.8% |
| FY2023 | $65.6M | +283.6% |
| FY2022 | $17.1M | +15.1% |
| FY2021 | $14.8M | -41.6% |
| FY2020 | $25.4M | +48.2% |
| FY2019 | $17.1M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice